Astellas Pharma (ALPMY)
(Delayed Data from OTC)
$9.47 USD
-0.02 (-0.21%)
Updated Apr 24, 2024 03:59 PM ET
4-Sell of 5 4
B Value F Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Bottom 42% (147 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.52 | 9.99 |
Current Quarter Estimate | NA | -2.04 | 60.00 |
Year Ago Quarter Estimate | 0.15 | -0.59 | 52.54 |
Next Quarter Estimate | NA | -2.00 | 61.00 |
Next Year Estimate | 0.45 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -73.63 | 10.10 | 5.37 |
Next Year | 87.50 | 13.20 | 11.11 |
Last 5 Years | -0.10 | 5.90 | 8.10 |
Next 5 Years | 14.00 | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 24.33 | -5.88 |
Price/Book (MRQ) | 1.68 | 1.73 |
Price/Cash Flow (MRFY) | 6.99 | 8.52 |
Dividend Yield | 3.54% | 0.00% |
Net Profit Margin (TTM) | 0.08% | -19.76% |
Return on Equity (TTM) | 6.39% | -75.03% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.